Risk factors and prodromal markers and the development of Parkinson’s disease

被引:0
|
作者
Stefanie Lerche
Klaus Seppi
Stefanie Behnke
Inga Liepelt-Scarfone
Jana Godau
Philipp Mahlknecht
Alexandra Gaenslen
Kathrin Brockmann
Karin Srulijes
Heiko Huber
Isabel Wurster
Heike Stockner
Stefan Kiechl
Johann Willeit
Arno Gasperi
Klaus Fassbender
Werner Poewe
Daniela Berg
机构
[1] University of Tuebingen,Department of Neurodegeneration and Hertie Institute for Clinical Brain Research, Center of Neurology
[2] University of Tuebingen,German Center for Neurodegenerative Diseases (DZNE)
[3] University of Innsbruck,Department of Neurology
[4] University of Homburg/Saar,Department of Neurology
[5] Bruneck Hospital,Department of Neurology
来源
Journal of Neurology | 2014年 / 261卷
关键词
Risk factor; Prodromal marker; Parkinson’s disease;
D O I
暂无
中图分类号
学科分类号
摘要
Identification of risk factors and prodromal markers for Parkinson’s disease (PD) and the understanding of the point in time of first occurrence is essential for the early detection of incident PD. In this three-center longitudinal, observational study, we evaluated the specific risk for PD associated with single or combinations of risk factors and prodromal markers. In addition, we evaluated which risk factors and prodromal markers emerge at which time before the diagnosis of PD. Of the 1,847 at-baseline PD-free individuals ≥50 years, 1,260 underwent the 5-year follow-up assessment. There were 21 cases of incident PD during the study period. Enlarged hyperechogenic substantia nigra was the most frequent baseline sign in individuals developing PD after 3 years (80.0 %) and 5 years (85.7 %) compared to healthy controls (17.5 %) followed by the occurrence of mild parkinsonian signs and hyposmia. Evaluation of the signs at the first follow-up assessment showed that individuals developing PD after two additional years showed the same pattern of signs as individuals who developed PD 3 years after baseline assessment.
引用
收藏
页码:180 / 187
页数:7
相关论文
共 50 条
  • [21] Relation of risk factors and putative premotor markers for Parkinson’s disease
    I. Liepelt-Scarfone
    S. Behnke
    J. Godau
    K. J. Schweitzer
    B. Wolf
    A. Gaenslen
    D. Berg
    Journal of Neural Transmission, 2011, 118 : 579 - 585
  • [22] Relation of risk factors and putative premotor markers for Parkinson's disease
    Liepelt-Scarfone, I.
    Behnke, S.
    Godau, J.
    Schweitzer, K. J.
    Wolf, B.
    Gaenslen, A.
    Berg, D.
    JOURNAL OF NEURAL TRANSMISSION, 2011, 118 (04) : 579 - 585
  • [23] Widening the Spectrum of Risk Factors, Comorbidities, and Prodromal Features of Parkinson Disease
    Schrag, Anette
    Bohlken, Jens
    Dammertz, Lotte
    Teipel, Stefan
    Hermann, Wiebke
    Akmatov, Manas K.
    Batzing, Jorg
    Holstiege, Jakob
    JAMA NEUROLOGY, 2023, 80 (02) : 161 - 171
  • [24] Prodromal Clinical Markers of Parkinson disease in Gaucher Disease Individuals
    Gatto, Emilia M.
    Etcheverry, Jose Luis
    Sanguinetti, Ana
    Cesarini, Martin
    Escobar, Nicolas Fernandez
    Drelichman, Guillermo
    EUROPEAN NEUROLOGY, 2016, 76 (1-2) : 19 - 21
  • [25] Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
    Vermeiren, Yannick
    Hirschberg, Yael
    Mertens, Inge
    De Deyn, Peter P.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [26] Electroencephalographic prodromal markers of dementia across conscious states in Parkinson's disease
    Latreille, Veronique
    Carrier, Julie
    Gaudet-Fex, Benjamin
    Rodrigues-Brazete, Jessica
    Panisset, Michel
    Chouinard, Sylvain
    Postuma, Ronald B.
    Gagnon, Jean-Francois
    BRAIN, 2016, 139 : 1189 - 1199
  • [27] Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned
    Heinzel, Sebastian
    Roeben, Benjamin
    Ben-Shlomo, Yoav
    Lerche, Stefanie
    Alves, Guido
    Barone, Paolo
    Behnke, Stefanie
    Berendse, Henk W.
    Bloem, Bastiaan R.
    Burn, David
    Dodel, Richard
    Grosset, Donald G.
    Hu, Michele
    Kasten, Meike
    Krueger, Rejko
    Moccia, Marcello
    Mollenhauer, Brit
    Oertel, Wolfgang
    Suenkel, Ulrike
    Walter, Uwe
    Wirdefeldt, Karin
    Liepelt-Scarfone, Inga
    Maetzler, Walter
    Berg, Daniela
    FRONTIERS IN AGING NEUROSCIENCE, 2016, 8
  • [28] Prodromal diagnosis of Parkinson's disease
    Montgomery, Erwin B., Jr.
    MOVEMENT DISORDERS, 2012, 27 (11) : 1467 - 1467
  • [29] Psychosis in Prodromal Parkinson's disease
    Pachi, I.
    Maraki, M.
    Kosmidis, M.
    Yannakoulia, M.
    Dardiotis, E.
    Hadjigeorgiou, G.
    Sakka, P.
    Xiromerisiou, G.
    Stamelou, M.
    Scarmeas, N.
    Stefanis, L.
    MOVEMENT DISORDERS, 2019, 34 : S154 - S154
  • [30] Editorial: Prodromal Parkinson's Disease
    Crosiers, David
    Santens, Patrick
    Chaudhuri, K. Ray
    FRONTIERS IN NEUROLOGY, 2021, 11